Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes? Let's find out.

UBS Group AG said it will carry out its plans to make payouts to shareholders this year as previously announced after the ...

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...

In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Huntington’s disease affects an estimated 5 to 10 per 100,000 people in most Western countries, with variation by region and ...

Novartis and Amgen also boast impeccable dividend track records, which should please investors. When broader equities are ...

Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the ...

Explore how nanomedicine and targeted therapies are shaping the future of cancer care in BCC Research’s global market analysis of nanotechnology in oncology.”Boston, June 05, 2025 (GLOBE NEWSWIRE) -- ...

The antidote market is witnessing substantial growth, largely propelled by the growing incidence of poisoning, drug overdoses, and snake or animal bites. This rising demand is supported by greater ...

QINT offers diversified exposure to international equities, with strong representation from innovative and market-leading ...

A Canadian non-profit organization with goals to address the health inequities in marginalized communities just got a huge financial boost.